Electrophysiological and fluorescence microscopy studies with HERG channel/EGFP fusion proteins

Journal of Membrane Biology

Volumn 222, Issue 1, 2008, Pages 31-41

  Claassen, Sonja ^a   Schwarzer, Sarah ^b   Ludwig, Jost ^b   Zünkler, Bernd J ^a  

^a FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Domperidone; Enhanced green fluorescent protein; HERG channel; Laser scanning confocal microscopy; Long QT syndrome; Patch clamp

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCENT DYE; HYBRID PROTEIN; POTASSIUM CHANNEL HERG; PROTEIN TAG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CYTOPLASM; ELECTROPHYSIOLOGY; EMBRYO; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LASER MICROSCOPY; MEMBRANE CURRENT; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PROTEIN DOMAIN; PROTEIN EXPRESSION; WILD TYPE;

CELL LINE; CELL MEMBRANE; CYTOPLASM; ETHER-A-GO-GO POTASSIUM CHANNELS; GREEN FLUORESCENT PROTEINS; HUMANS; MICROSCOPY, CONFOCAL; POTASSIUM; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; TORSADES DE POINTES;

EID: 43049129604     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-008-9101-0     Document Type: Article

References (31)

1. Anderson CL, Delisle BP, Anson BD, Kilby JA, Will ML, Tester DJ, Gong Q, Zhou Z, Ackerman MJ, January CT (2006) Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 113:365-373
2. Claassen S, Zünkler BJ (2005) Comparison of the effects of metoclopramide and domperidone on HERG channels. Pharmacology 74:31-36
3. Cordes JS, Sun Z, Lloyd DB, Bradley JA, Opsahl AC, Tengowski MW, Chen X, Zhou J (2005) Pentamidine reduces hERG expression to prolong the QT interval. Br J Pharmacol 145:15-23
4. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80:795-803
5. Drolet B, Rousseau G, Daleau P, Cardinal R, Turgeon J (2000) Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 102:1883-1885
6. Ficker E, Kuryshev YA, Dennis AT, Obejero-Paz C, Wang L, Hawryluk P, Wible BA, Brown AM (2004) Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol 66:33-44
7. Furutani M, Trudeau MC, Hagiwara N, Seki A, Gong Q, Zhou Z, Imamura S, Nagashima H, Kasanuki H, Takao A, Momma K, January CT, Robertson GA, Matsuoka R (1999) Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation 99:2290-2294
8. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pfluegers Arch 391:85-100
9. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59
10. Jenke M, Sanchez A, Monje F, Stühmer W, Weseloh RM, Pardo LA (2003) C-terminal domains implicated in the functional surface expression of potassium channels. EMBO J 22:395-403
11. Kupershmidt S, Yang T, Chanthaphaychith S, Wang Z, Towbin JA, Roden DM (2002) Defective human ether-a-go-go-related gene trafficking linked to an endoplasmic retention signal in the C-terminus. J Biol Chem 277:27442-27448
12. Kuryshev YA, Ficker E, Wang L, Hawryluk P, Dennis AT, Wible BA, Brown AM, Kang J, Chen X-L, Sawamura K, Reynolds W, Rampe D (2005) Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther 312:316-323
13. Limon A, Reyes-Ruiz JM, Eusebi F, Miledi R (2007) Properties of GluR3 receptors tagged with GFP at the amino or carboxyl terminus. Proc Natl Acad Sci USA 104:15526-15530
14. Maguy A, Hebert TE, Nattel S (2006) Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc Res 69:798-807
15. O'Connell KMS, Tamkun MM (2005) Targeting of voltage-gated potassium channel isoforms to distinct cell surface microdomains. J Cell Sci 118:2155-2166
16. O'Connell KMS, Martens JR, Tamkun MM (2004) Localization of ion channels to lipid raft domains within the cardiovascular system. Trends Cardiovasc Med 14:37-42
17. Paulussen A, Raes A, Matthijs G, Snyders DJ, Cohen N, Aerssens J (2002) A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency. J Biol Chem 277:48610-48616
18. Paulussen ADC, Raes A, Jongbloed RJ, Gilissen RAHJ, Wilde AAM, Snyders DJ, Smeets HJM, Aerssens J (2005) HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency. Cardiovasc Res 67:467-475
19. Petrecca K, Atanasiu R, Akhavan A, Shrier A (1999) N-Linked glycosylation sites determine HERG channel surface membrane expression. J Physiol 515:41-48
20. Rossenbacker T, Mubagwa K, Jongbloed RJ, Vereecke J, Devriendt K, Gewillig M, Carmeliet E, Collen D, Heidbüchel H, Carmeliet P (2005) Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome. Circulation 111:961-968
21. Sanguinetti MC, Mitcheson JS (2005) Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends Pharmacol Sci 26:119-124
22. Sanguinetti MC, Jiang C, Curran ME, Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia. Cell 81:299-307
23. Sasano T, Ueda K, Orikabe M, Hirano Y, Kawano S, Yasunami M, Isobe M, Kimura A, Hiraoka M (2004) Novel C-terminus frameshift mutation, 1122fs/147, of HERG in LQT2: additional amino acids generated by frameshift cause accelerated inactivation. J Mol Cell Cardiol 37:1205-1211
24. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT (2000) Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102:1178-1185
25. Sun H, Liu X, Xiong Q, Shikano S, Li M (2006) Chronic inhibition of cardiac Kir2.1 and hERG potassium channels by celastrol with dual effects on both ion conductivity and protein trafficking. J Biol Chem 281:5877-5884
26. Teng S, Ma L, Dong Y, Lin C, Ye J, Bähring R, Vardanyan V, Yang Y, Lin Z, Pongs O, Hui R (2004) Clinical and electrophysiological characterization of a novel mutation R863X in HERG C-terminus associated with long QT syndrome. J Mol Med 82:189-196
27. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA (1995) HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 269:92-95
28. + channel: progress in understanding the molecular basis of its unusual gating kinetics. Eur Biophys J 33:89-97
29. Wang L, Wible BA, Wan X, Ficker E (2007) Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking. J Pharmacol Exp Ther 320:525-534
30. Warmke JW, Ganetzky B (1994) A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 91:3438-3442
31. Zünkler BJ (2006) Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects. Pharmacol Ther 112:12-37